Table 2 Patient characteristics (N = 5552)
From: Frequency of thyroid function tests and examinations in participants of a population-based study
Number (N) | Percent (%) | 95% CI | |
|---|---|---|---|
Sex (male) | 2602 | 46.9 | 45.5–48.2 |
Age | |||
≤ 30 | 327 | 5.9 | 5.3–6.5 |
> 30–50 | 1876 | 33.8 | 32.5–35.0 |
> 50–80 | 3237 | 58.3 | 57.0–59.6 |
> 80 | 112 | 2.0 | 1.7–2.4 |
Pregnant women | 8 | 0.1 | 0.04–0.2 |
BMI > 30 | 1825 | 32.8 | 31.6–34.1 |
Thyroid medication | 638 | 11.5 | 10.6–12.3 |
CCI | |||
0 | 3049 | 54.9 | 53.6–56-2 |
1 | 1390 | 25.0 | 23.9–26.2 |
2–5 | 1038 | 18.7 | 17.7–19.7 |
6–12 | 36 | 0.7 | 0.4–0.9 |
SHIP diagnosisa, c | |||
Goitre | 1815 | 32.7 | 31.5–33.9 |
Hyperthyroidism | 510 | 9.2 | 8.4–9.9 |
Hypothyroidism | 611 | 11.1 | 10.2–11.8 |
Thyroid nodule | 2197 | 39.6 | 38.3–40.9 |
Thyroiditis | 234 | 4.2 | 3.7–4.7 |
Billing diagnosisb, c | |||
Goitre | 1057 | 19.0 | 18.0–20.1 |
Hyperthyroidism | 230 | 4.1 | 3.6–4.7 |
Hypothyroidism | 320 | 5.8 | 5.2–6.4 |
Thyroid nodule | 500 | 9.0 | 8.2–9.8 |
Thyroiditis | 166 | 2.99 | 2.5–3.4 |